Should Investors Buy Pfizer (PFE) & Moderna (MRNA) Stock for 2023?

01:28am, Tuesday, 06'th Dec 2022 Zacks Investment Research
Much of the social and economic post-pandemic recovery is accredited to Covid-19 vaccine makers Pfizer (PFE) and Moderna (MRNA). Investors may be wondering if these stocks will continue to be strong i

Relative Strength Found Within These 3 Medical Stocks

10:35pm, Monday, 05'th Dec 2022 Zacks Investment Research
The Zacks Medical sector has modestly outperformed the S&P 500 over the last three months, up more than 7% vs. the general market's 4% gain.
Much of the social and economic post-pandemic recovery is accredited to Covid-19 vaccine makers Pfizer (PFE) and Moderna (MRNA). Investors may be wondering if these stocks will continue to be strong i
The Zacks Medical sector has modestly outperformed the S&P 500 over the last three months, up more than 7% vs. the general market's 4% gain.
Pfizer Inc. PFE, -0.77% and BioNTech SE BNTX, -1.63% said Monday that they asked the Food and Drug Administration to authorize their updated COVID-19 vaccine as the third dose for children between the

7 Stocks for Beginners to Buy Now

08:15pm, Sunday, 04'th Dec 2022
The coronavirus pandemic combined with the rise of stock trading apps led to a sharp increase in the number of retail traders. Much has been written about these new investors — many of whom are youn

Here's How to Prepare Your Portfolio for 2023

11:00am, Sunday, 04'th Dec 2022 The Motley Fool
Efforts now could result in gains next year and beyond.

Here's How to Prepare Your Portfolio for 2023

06:00am, Sunday, 04'th Dec 2022
Efforts now could result in gains next year and beyond.

FTX Collapse: Lessons for Investors

05:55pm, Saturday, 03'rd Dec 2022 The Motley Fool
Plus a look at "the dumbest index."

Is Veeva Systems Stock a Buy Now?

02:03pm, Saturday, 03'rd Dec 2022 The Motley Fool
The cloud-based customer relationship management company faces a lot of near-term headwinds.
In this article, we select 5 conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges. Learn more about our process and picks here.

Roivant (ROIV), Pfizer Form Vant for Inflammatory Disease Drug

04:05pm, Friday, 02'nd Dec 2022 Zacks Investment Research
Roivant Sciences (ROIV), Pfizer's (PFE) new Vant company will take care of funding the global development of RVT-3101 in inflammatory and fibrotic diseases.

Valneva (VALN) Up on 6-Month Lyme Disease Jab Persistence Data

03:54pm, Friday, 02'nd Dec 2022 Zacks Investment Research
Persistence data from a mid-stage study showed that Valneva's (VALN) Lyme disease vaccine elicited antibody levels which remained above baseline six months after completing dose administration in chil
Pfizer (PFE) and Roivant Sciences (ROIV) form a new Roivant subsidiary to develop an inflammatory disease drug. AstraZeneca (AZN) to boost cell therapies portfolio with private company buyout.
Is now a good time to add these biotech stocks to your watchlsit?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE